These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15891521)

  • 1. Employees with overactive bladder: work loss burden.
    Wu EQ; Birnbaum H; Marynchenko M; Mareva M; Williamson T; Mallett D
    J Occup Environ Med; 2005 May; 47(5):439-46. PubMed ID: 15891521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence and adherence with urinary antispasmodic medications among employees and the impact of adherence on costs and absenteeism.
    Kleinman NL; Odell K; Chen CI; Atkinson A; Zou KH
    J Manag Care Spec Pharm; 2014 Oct; 20(10):1047-56. PubMed ID: 25278327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost of disability and medically related absenteeism among employees with multiple sclerosis in the US.
    Ivanova JI; Birnbaum HG; Samuels S; Davis M; Phillips AL; Meletiche D
    Pharmacoeconomics; 2009; 27(8):681-91. PubMed ID: 19712010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. United States comparative costs and absenteeism of diabetic ophthalmic conditions.
    Brook RA; Kleinman NL; Patel S; Smeeding JE; Beren IA; Turpcu A
    Postgrad Med; 2015 Jun; 127(5):455-62. PubMed ID: 25549691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Annual incremental health benefit costs and absenteeism among employees with and without rheumatoid arthritis.
    Kleinman NL; Cifaldi MA; Smeeding JE; Shaw JW; Brook RA
    J Occup Environ Med; 2013 Mar; 55(3):240-4. PubMed ID: 23471034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health and disability costs of depressive illness in a major U.S. corporation.
    Druss BG; Rosenheck RA; Sledge WH
    Am J Psychiatry; 2000 Aug; 157(8):1274-8. PubMed ID: 10910790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 on work loss in the United States- A retrospective database analysis.
    Judy J; Yehoshua A; Gouveia-Pisano J; Brook RA; Kleinman NL; Drnach AA; Rosenberg EM; Ghanjanasak T; Winter DA; Dai F; Escobar JM; Sell H
    J Med Econ; 2024; 27(1):941-951. PubMed ID: 38984895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of bipolar disorder in an employed population from an employer perspective.
    Gardner HH; Kleinman NL; Brook RA; Rajagopalan K; Brizee TJ; Smeeding JE
    J Clin Psychiatry; 2006 Aug; 67(8):1209-18. PubMed ID: 16965198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and absence of HCV-infected employees by disease stage.
    Baran RW; Samp JC; Walker DR; Smeeding JE; Young JW; Kleinman NL; Brook RA
    J Med Econ; 2015; 18(9):691-703. PubMed ID: 26047262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct and indirect costs among U.S. privately insured employees with hypogonadism.
    Kaltenboeck A; Foster S; Ivanova J; Diener M; Bergman R; Birnbaum H; Kinchen K; Swindle R
    J Sex Med; 2012 Sep; 9(9):2438-47. PubMed ID: 22738380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated economic costs of overactive bladder in the United States.
    Hu TW; Wagner TH; Bentkover JD; LeBlanc K; Piancentini A; Stewart WF; Corey R; Zhou SZ; Hunt TL
    Urology; 2003 Jun; 61(6):1123-8. PubMed ID: 12809878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden of urgency urinary incontinence in the United States: a systematic review.
    Coyne KS; Wein A; Nicholson S; Kvasz M; Chen CI; Milsom I
    J Manag Care Pharm; 2014 Feb; 20(2):130-40. PubMed ID: 24456314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of acute coronary syndromes for employees and their dependents: medical and productivity costs.
    Page RL; Ghushchyan V; Gifford B; Read RA; Raut M; Crivera C; Naim AB; Damaraju CV; Nair KV
    J Occup Environ Med; 2013 Jul; 55(7):761-7. PubMed ID: 23787565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of urinary incontinence and overactive bladder in the United States: a comparative study.
    Hu TW; Wagner TH; Bentkover JD; Leblanc K; Zhou SZ; Hunt T
    Urology; 2004 Mar; 63(3):461-5. PubMed ID: 15028438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort analysis assessing medical and nonmedical cost associated with obesity in the workplace.
    Kleinman N; Abouzaid S; Andersen L; Wang Z; Powers A
    J Occup Environ Med; 2014 Feb; 56(2):161-70. PubMed ID: 24451611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between employee obesity and employer costs: evidence from a panel of U.S. employers.
    Van Nuys K; Globe D; Ng-Mak D; Cheung H; Sullivan J; Goldman D
    Am J Health Promot; 2014; 28(5):277-85. PubMed ID: 24779722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dyspepsia impacts absenteeism and direct and indirect costs.
    Brook RA; Kleinman NL; Choung RS; Melkonian AK; Smeeding JE; Talley NJ
    Clin Gastroenterol Hepatol; 2010 Jun; 8(6):498-503. PubMed ID: 20304102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Direct and Indirect Costs Associated With Overactive Bladder Within a Commercially-Insured Population in the United States.
    Durden E; Walker D; Gray S; Fowler R; Juneau P; Gooch K
    J Occup Environ Med; 2018 Sep; 60(9):847-852. PubMed ID: 29851742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Loss of Work Productivity in Patients with Overactive Bladder Treated with Antimuscarinics in Spain: Study in Routine Clinical Practice Conditions.
    Sicras-Mainar A; Navarro-Artieda R; Ruiz-Torrejón A; Sáez-Zafra M; Coll-de Tuero G
    Clin Drug Investig; 2015 Dec; 35(12):795-805. PubMed ID: 26464261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.